Summary Cancer incidence was studied among 3072 first-degree relatives of 559 unselected ovarian cancer patients. Among cohort members there were 306 cancer cases. The overall cancer incidence was not increased: the standardised incidence ratio (SIR) in males was 0.9 (95% confidence interval 0.8-1.1) and in females 1.0 (0.8 -1.1). The female relatives had a significantly increased risk for ovarian cancer (SIR 2.8, 1.8-4.2). The excess was attributable to sisters only (SIR 3.7, 2.3 -5.7). The relative risk for ovarian cancer among sisters decreased both by increasing age of the sister and by increasing age at diagnosis of the index patient: the SIRs were 7.3 (1.5-21.4), 4.5 (1.6-9.8) and 3.1 (1.7-5.4) for sisters of index patients diagnosed in age <45, 45 -54 and 55 -75 years respectively. The age dependency of the risk supports the role of genetic factors in familial ovarian cancer. Although the risk of ovarian cancer among sisters from families with breast cancer (SIR 9.2, 3.7-19.0) was significantly higher than among sisters from families with no breast cancer patients (SIR 2.9, 1.6-4.8, rate ratio 3.1, P < 0.05), the excess was not solely attributable to coaggregation of breast and ovarian cancer. Among the 27 families with two or more ovarian cancers, only sisters were affected in 24 families, which might implicate recessive inheritance or shared environmental factors influencing ovarian cancer risk in sisters.
One of the strongest known risk factors for epithelial ovarian cancer is family history of the disease (Hartge et al., 1989) . In case-control studies including sufficient numbers of patients, the age-adjusted relative risk estimates for the first-degree female relatives of ovarian cancer patients have ranged from 1.9 to 4.5 (Parazzini et al., 1992; Houlston et al., 1993; Hartge et al., 1989; Schildkraut et al., 1989; Kerber and Slattery, 1995) . In a combined analysis of seven case-control studies with altogether 1122 patients with an invasive epithelial ovarian carcinoma and 5359 controls, the ageadjusted relative risk was estimated to be 5.4 (Hartge et al., 1994) . Familial aggregation of ovarian cancer, originally detected in individual families (Liber, 1950; Lewis and Clare Davison, 1969; Li et al., 1970; Fraumeni et al., 1975; Thor et al., 1976) , is thus convincingly demonstrated also in epidemiological studies.
Causes for this familial aggregation are largely unknown. An undetermined fraction of familial ovarian cancer is probably caused by inherited mutations in the recently cloned gene BRCAI (Miki et al., 1994; Shattuck-Eidens et al., 1995) . Mutations in the BRCAJ gene are estimated to be involved in 92% of breast-ovarian cancer families (Narod et al., 1995) , but site-specific ovarian cancer has also been reported to be linked to this gene (Steichen-Gersdorf et al., 1994) . Inherited mutations in the genes involved in the hereditary non-polyposis colorectal cancer, HNPCC, also predispose to ovarian cancer (Lynch et al., 1986; Mecklin and Jarvinen 1991; Aaltonen et al., 1994) . However, the most common form of familiality of ovarian cancer is the occurrence of only two ovarian cancer cases in the family, without features of these dominantly inherited cancer syndromes (Piver et al., 1993; Greggi et al., 1990; Grover et al., 1993) .
The present study aims to give a more precise picture of the familial risk of ovarian cancer than has been possible in previous studies. Cancer in reladves of ovarian cancer padents A Auranen et a! unlikely. The parents and siblings were followed up through the parish records until death or until they obtained a personal identification number. The data on the children and husbands were obtained from the parishes or the Central Population Register. The data on relatives were linked with the Central Population Register in February 1994 to obtain dates of death of the relatives.
Tracing of family members was successful for 700 (81%) of the 863 index patients. Failure to trace the family members was due to: inability to find the patient in the population registries of her reported birthplace, probably owing to inaccurately provided birthplace (90 patients), lack of response from the local officials (25 patients), born abroad (five patients) or failure to follow the family until additional children were considered unlikely, caused by the fact that the family had changed location repeatedly (43 patients).
Among the above 700 families, follow-up for 273 persons altogether in 141 families had to be interrupted for practical causes before death or assignment of a personal identification number. In the remaining 559 families all the family members were followed up. The final analysis was restricted to these 559 families. The distribution of the 559 index patients according to age and histology is presented in Table I .
Statistical methods
The relatives were followed up for cancer through the files of the Finnish Cancer Registry. For relatives who died in the period 1953 to 1966 the follow-up was done manually using the alphabetical patient name files with date of birth and place of birth and residence as an additional key. For those alive after 1 January 1967 the follow-up was done automatically using the personal identification number as the key. For mothers and sisters deceased during the period 1936-52, death certificates were obtained to verify the cause of death. For people deceased before 1936, death certificates are not available.
To validate the data and to determine the starting point of the analysis, the overall cancer risk was first calculated separately for the period 1953-1966. The standardised incidence ratios (SIRs) for overall cancer in females and males were 0.7 (95% CI 0.5-1.0) and 0.7 (95% CI 0.5-1.0) respectively. This significant risk deficit was considered to reflect problems encountered in the manual follow-up of the relatives. In consequence, the data were not considered reliable for the period [1953] [1954] [1955] [1956] [1957] [1958] [1959] [1960] [1961] [1962] [1963] [1964] [1965] [1966] , and the main analysis was restricted to the period starting from 1 January 1967.
Follow-up for cancer among parents of the index patients started at date of birth of the index patient or on 1 January 1967, whichever was later, and ended at death or on 31 December 1993, whichever was first. For siblings and children the follow-up started at the date of their birth or on 1 January 1967, whichever was later. Siblings' personyears at risk during the follow-up were categorised into four age groups. The numbers of observed cases and person-years at risk in each relative category were counted, by five year age groups, separately for three calendar periods (1967-75, 1976-84 and 1985-93) . The expected numbers of cases for total cancer and for specific cancer types were calculated by multiplying the number of person-years in each age group by the corresponding period-specific cancer incidence in all of Finland.
The specific cancer types selected a priori for the analysis included the cancer sites with known or suspected exceptional risk in earlier studies, and other common cancer types to give the whole picture of the cancer situation among the cohort. The selected cancers were: ovary, breast, cervix uteri, endometrium, prostate, stomach, colon, rectum, lung, pancreas and melanoma of the skin.
Because of the definition of the index patients, the expected number for ovarian cancer during the period 1980-82 in ages below 75 was subtracted from the total expected number of cases for female overall cancer and ovarian cancer. The decision to exclude observed and expected numbers for the whole period 1980-82 is unbiased. There were no families with more than one ovarian cancer diagnosed in 1980-82.
Standardised incidence ratios (SIRs) were defined as ratios of the observed to the expected number of cases. The statistical significance was tested by the Mantel -Haenszel chi-square test and 95% confidence intervals (CIs) were calculated on the presumption that the number of observed cases followed a Poisson distribution.
Results
In the 559 families there were 6501 first-degree relatives. Ovarian cancer was diagnosed in 31 relatives from 27 families. Eight of the cancers were diagnosed before the start of the follow-up period in 1967. Two ovarian cancers were present in 23 families (4.1% of all families) and three ovarian cancers in four families (0.7% of all families). Three mothers and 28 sisters were affected. In the four families with three ovarian cancer patients, only sisters were affected in two families and two sisters and a mother in one family. In the fourth family, only sisters were affected with ovarian cancer, but the mother had an abdominal cancer of undefined origin. Breast cancer was present in ten of these 27 families.
Of the relatives, 3072 were at risk on 1 January 1967 or thereafter. They were followed up for a total of 69 793 person-years (mean 23 years). The overall risk of cancer was not increased among the relatives (Table II) . Female relatives had a significantly increased 2.8-fold risk (95% CI 1.8-4.2) for ovarian cancer, but no other significantly increased or decreased risks were observed (Table III) . The mothers' SIR for ovarian cancer was 0.6 (0.0-3.1) while the sisters' SIR (Table IV) . Apart from ovarian cancer, no significantly increased or decreased risks were observed when the mothers and sisters were analysed separately. The SIR for breast cancer in mothers was 0.9 (0.4-1.8) and in sisters 1.0 (0.6-1.4). In sisters, stratification of the data according to the age at diagnosis of the index patients into three groups (<45 years, 45-54 years and 55-75 years) revealed that the sisters of the youngest index patients had a significantly increased overall cancer risk (SIR 2.1, 1.1-3.6) and the risk was concentrated in sisters aged 45 to 59 years (SIR 2.9, CI 1.4-6.0). This excess was attributable to ovarian cancer only.
No significantly increased or decreased risks were observed in the male relatives (Table III) . Division of the males into fathers and brothers did not change the results. For brothers, the data were further stratified according to the age of the index patient into three age groups, as described above. No increase in overall cancer risk or risk for any specific cancer was observed in any age category.
Of the 918 sisters at risk, 118 (13%) sisters belonged to families with breast cancer (either in index patient or relative). The risk of ovarian cancer was significantly higher among sisters from families with breast cancer (SIR 9.2, 3.7-19, n=7) compared with sisters from families with no breast cancer patients (SIR 2.9, 1.6-4.8, n= 15, rate ratio 3.1, P < 0.05). In the 27 families with two or more ovarian cancers, 1.6 breast cancers were expected in the sisters but seven were (Parazzini et al., 1992; Narod et al., 1994; Kerber and Slattery 1995) , while other studies suggest that familial occurrence of ovarian cancer is increased at younger (Lynch et al., 1993; Houlston et al., 1993) or older (Schildkraut et al., 1989) ages at onset.
The relation of young age to the familiality of the disease, observed in this study, is typical for inherited predisposition and resembles the pattern previously observed (Houlston et al., 1993) . Their data were collected from healthy relatives consulting an ovarian cancer screening clinic. Since relatives of younger cancer patients could be presumed to be more worried about the familiality of cancer than relatives of older patients, a possible bias towards younger index patients might have occurred in their study. Such a bias does not exist in our population-based study.
The observation that only sisters had an increased risk for ovarian cancer, whereas no increase in risk could be observed for mothers, would speak for a recessive rather than a dominant mode of transmission. However, close to 50% of mothers were deceased before the follow-up period. During the follow-up period starting from 1967, the number of person-years at risk for mothers at younger ages is limited and the age patterns of person-years at risk are different for mothers and sisters. The overall difference between the SIRs of the sisters and mothers (higher SIR among sisters than mothers) is not statistically significant, and because of the decreasing relative risk by increasing age, adjustment for age would further diminish this difference.
When the causes of death for relatives who died before 1967 were verified from death certificates or from the Finnish Cancer Registry, only two further ovarian cancers were found among the mothers. The notable lack of ovarian cancer in the mothers may implicate recessive inheritance or shared environmental risk factors in sisters. Although the findings 283 in most studies speak for a dominantly inherited predisposition (Houlston et al.. 1991 : Lynch et al.. 1991 . the possibility of a recessive inheritance, based on the observation of consanguinity among patients with ovarian cancer. has also been raised (Cramer et al.. 1983 ). In the OPCS study from England and Wales (Easton et al.. 1996) , sisters of ovarian cancer cases had higher mortality from this disease than mothers. which supports the observations in the present study.
We did not detect an increase in breast cancer risk among all the relatives of the ovarian cancer patients. Ovarian cancer is known to be genetically related to breast cancer in the breast-ovarian cancer syndrome (Lynch et al.. 1974; Go et al.. 1983) . which is mainly caused by inherited mutations in the recently cloned BRCA1 gene (Miki et al., 1994; Narod et al.. 1995 
